Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016 [0.03%]
美国商业保险成人患者人群2009～2016年间普瑞巴林处方情况分析
Nathan J Pauly,Chris Delcher,Svetla Slavova et al.
Nathan J Pauly et al.
Background: Gabapentin is prescribed for a variety of conditions and is often used off label. It is important to understand the prevalence of gabapentin prescribing and the characteristics of individuals who are prescribe...
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research [0.03%]
纵向图示法在管理照护药房研究中的应用
Laura E Happe,Joshua D Brown,Justin Gatwood et al.
Laura E Happe et al.
Managed care pharmacists apply real-world evidence (RWE) to support activities such as pipeline forecasting, clinical policy development, and contracting for pharmaceutical products. Managed care pharmacy researchers strive to produce studi...
Gordon J Vanscoy
Gordon J Vanscoy
Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema [0.03%]
雷珠单抗和阿柏西普治疗年龄相关性黄斑变性和糖尿病黄斑水肿的现实世界注射频率及费用分析
Szilárd Kiss,Elisabetta Malangone-Monaco,Kathleen Wilson et al.
Szilárd Kiss et al.
Background: Ranibizumab and aflibercept are FDA-approved treatments for patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Although these agents differ in cost and labeled ...
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products [0.03%]
美国血友病A患者接受3种不同长效重组FVIII产品预防治疗的因子使用和出血率比较
Mindy L Simpson,Vidhi Desai,Géraldine S Maro et al.
Mindy L Simpson et al.
Background: Recombinant factor VIII (rFVIII) products have been developed with improved pharmacokinetics, offering some patients the potential to extend dosing intervals, thereby reducing their dosing frequency while mini...
Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer [0.03%]
恩扎卢胺治疗非转移性去势抵抗性前列腺癌的预算影响分析
Neil M Schultz,Ken O&#x;Day,Rebecca Sugarman et al.
Neil M Schultz et al.
Background: Prostate cancer is the most common cancer and second-leading cause of cancer death among men in the United States. Prostate cancer poses a large economic burden, which increases with progression from localized...
Changes in Concurrent Opioid and Benzodiazepine Use Following a Low-Touch Prescriber Fax Intervention [0.03%]
低成本医师干预减少联用阿片类和苯二氮卓类药物的现象
Rochelle Yang,Sara E Carruth,Wenyi Amanda Qiu et al.
Rochelle Yang et al.
Background: Concurrent use of opioids and benzodiazepines (COB) can lead to additive respiratory and central nervous system effects, putting patients at increased risk of fatal overdose. In 2016, the Centers for Disease C...
Editor's Note [0.03%]
编者按
Laura E Happe
Laura E Happe
The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic [0.03%]
集成卫生系统专科药房对门诊传染病诊所HIV抗逆转录病毒治疗依从性、抑制病毒和CD4计数的影响
Elizabeth Barnes,Jing Zhao,Adam Giumenta et al.
Elizabeth Barnes et al.
Background: Adherence to antiretroviral (ARV) therapy is critical in order to achieve and maintain viral suppression and improve immune function. Clinical pharmacists and pharmacies focused on human immunodeficiency virus...
Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [0.03%]
口服抗肿瘤药物治疗多发性骨髓瘤或慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的用药依从性、医疗利用率和成本分析
Ankur A Dashputre,Katie S Gatwood,Justin Gatwood
Ankur A Dashputre
Background: Oral oncolytic therapies have improved survival in hematologic cancers, such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and multiple myeloma (MM), which are now being managed like chr...